Drugs / Remifentanil
last change 10 days ago re-read 8 days ago

Remifentanil

Small molecule targets OPRM1 via activation

Developed for
delirium · osteoarthritis · substance-related disorder · cardiac rhythm disease · cardiac valvular defect · chronic pain syndrome · hypertensive disorder · hypotensive disorder
+22 more · respiratory distress syndrome in premature infants · respiratory failure · acquired aneurysmal subarachnoid hemorrhage · acute kidney injury · acute respiratory failure · crush syndrome · hyperglycemia · intracerebral hemorrhage · myocardial ischemia · neuropathy, painful · postherpetic neuralgia · thyroid gland disorder · traumatic brain injury · urolithiasis · leiomyoma · lung disorder · nose, anomalous shape of · outlet dysfunction constipation · pain agnosia · potassium deficiency · pulmonary immaturity · subacute delirium
Investigated by
Ajou University School of Medicine · Yonsei University · Seoul National University Hospital · GlaxoSmithKline · Changhai Hospital · Medical University of Vienna
+214 more · Shanghai Zhongshan Hospital · Hopital Foch · Ruijin Hospital · Shanghai Pulmonary Hospital, Shanghai, China · Assistance Publique - Hôpitaux de Paris · Capital Medical University · Medical University of Silesia · Nîmes University Hospital · Oslo University Hospital · Region Skane · Severance Hospital · Tri-Service General Hospital (TSGH) · University Hospital, Clermont-Ferrand · Ankara City Hospital Bilkent · Baylor College of Medicine · Beijing Tiantan Hospital · Boston Children's Hospital · Brasilia University Hospital · CMC Ambroise Paré · Catholic University of the Sacred Heart · Children's Hospital of Philadelphia · Gangnam Severance Hospital · Hallym University Medical Center · Jeju National University School of Medicine · KK Women's and Children's Hospital · Kaohsiung Medical University Chung-Ho Memorial Hospital · Murdoch Childrens Research Institute · Region Örebro County · Royal Children's Hospital · Southeast University, China · Sydney Children's Hospitals Network · The Cleveland Clinic · The Hospital for Sick Children · University Hospital, Geneva · University Hospital, Ghent · University Hospital, Toulouse · University Medical Center Groningen · University of California, San Francisco · Yangzhou University · AZ Sint-Jan AV · Aalborg University Hospital · Alder Hey Children's NHS Foundation Trust · Anders Troelsen · Arthritis Research UK · Azienda Ospedaliera San Gerardo di Monza · Basque Health Service · Beth Israel Deaconess Medical Center · Bezmialem Vakif University · C. R. Bard · Central Hospital, Nancy, France · Central South University · Centre Hospitalier Sud Francilien · Centre Hospitalier Universitaire Vaudois · Centre Hospitalier Universitaire de Besancon · Charles University, Czech Republic · Children's Hospital Medical Center, Cincinnati · Chosun University Hospital · Chun Pan · Ciusss de L'Est de l'Île de Montréal · Columbia University · Cukurova University · Department of Biostatistics, Southern Medical University · Diskapi Teaching and Research Hospital · Diskapi Yildirim Beyazit Education and Research Hospital · Dr. Erfan and Bagedo General Hospital · Duke University · Erasme University Hospital · Fatih Sultan Mehmet Training and Research Hospital · Federal University of Minas Gerais · Fifth Affiliated Hospital, Sun Yat-Sen University · First Affiliated Hospital of Harbin Medical University · First Affiliated Hospital of Kunming Medical University · First Affiliated Hospital of Xinjiang Medical University · Flinders Medical Centre · all 220 on the full record

Regulatory milestones approvals, filings & regulatory actions · 3 recorded

MilestoneJurisdictionBrandIndicationDateSentence it was read from
Label expansions (2) US (FDA) ULTIVA — 1999-10-15 – 2004-03-08 fda.gov ↗
Approved US (FDA) ULTIVA — 1996-07-12 fda.gov ↗

Trials 224 · started per year

today
US approved 1996
1
2
3
4
6
6
10
8
13
9
16
14
13
16
12
7
11
11
6
12
3
14
9
5
12
199619971998199920002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025202620272028
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 02 trials · 1 missed
Phase 0 NCT06312657 Mar 2023 → Mar 2025 substance-related disorder University of Kentucky Terminated No outcome recorded Stop: Business
Phase 0 NCT02898792 Sep 2016 → May 2018 sleep apnea syndrome Washington University School of Medicine Completed Missed primary
Phase 15 trials
Phase 1 NCT07603596 May 2026 → Apr 2028 expected delirium, digestive system neoplasm Qianfoshan Hospital Not yet recruiting No outcome recorded
Phase 1 NCT04670471 Apr 2021 → Jan 2022 — Paion UK Ltd. Completed No outcome recorded
Phase 1 NCT04301895 Apr → Sep 2019 acute opioid poisoning, respiratory underresponsiveness to hypoxia and hypercapnia University of California, San Francisco Completed No outcome recorded
Phase 1 NCT02473354 Apr 2015 → Apr 2018 respiratory underresponsiveness to hypoxia and hypercapnia Duke University Completed No outcome recorded
Phase 1 NCT02602002 Apr → Jun 2008 — GlaxoSmithKline Completed No outcome recorded
Phase 1/24 trials
Phase 1/2 NCT03928366 Jun 2017 → Jan 2019 codeine toxicity Parc de Salut Mar Completed No outcome recorded
Phase 1/2 NCT01477892 Dec 2011 → Apr 2012 — Seoul National University Hospital Completed No outcome recorded
Phase 1/2 NCT00213239 Sep 2005 → Sep 2007 hematologic disorder, neoplasm The Hospital for Sick Children Completed No outcome recorded
Phase 1/2 NCT00730054 Feb → May 2005 — Oslo University Hospital Completed No outcome recorded
Phase 26 trials
Phase 2 NCT04204967 Feb 2021 → Apr 2024 respiratory failure Fondazione Policlinico Universitario Agostino Gemelli IRCCS Completed No outcome recorded
Phase 2 NCT03443518 Feb → Nov 2018 — Dr. Erfan and Bagedo General Hospital Completed No outcome recorded
Phase 2 NCT02432677 Jul 2014 → Dec 2015 — Hospital de Clinicas de Porto Alegre Unknown No outcome recorded
Phase 2 NCT00522587 Apr 2008 → Jul 2009 — University Hospital, Ghent Completed No outcome recorded
Phase 2 NCT00693160 Dec 2007 → Oct 2010 — Wake Forest University Terminated No outcome recorded
Phase 2 NCT00315536 May 2006 → Apr 2009 — University Hospital, Ghent Completed No outcome recorded
Phase 2/31 trial
Phase 2/3 NCT05391555 Oct 2022 → Jun 2023 abnormal pupillary function, poisoning, respiratory underresponsiveness to hypoxia and hypercapnia University of California, San Francisco Completed No outcome recorded
Phase 320 trials · 1 met primary · 3 missed
Phase 3 NCT05641909 Aug 2021 → Dec 2022 — Southeast University, China Unknown No outcome recorded
Phase 3 NCT05003570 Jun 2021 → Dec 2022 — Southeast University, China Unknown No outcome recorded
Phase 3 NCT03960801 Oct 2019 → Apr 2021 — Nantes University Hospital Completed Missed primary
Phase 3 NCT03618082 Jun 2019 → May 2022 — University Hospital, Clermont-Ferrand Unknown No outcome recorded
Phase 3 NCT03089905 Aug 2017 → Oct 2026 expected poisoning Murdoch Childrens Research Institute Active not recruiting No outcome recorded
Phase 3 NCT03065309 Feb 2017 hypotensive disorder Brasilia University Hospital Completed No outcome recorded
Phase 3 NCT02597699 Dec 2015 → Mar 2019 — University Hospital, Montpellier Completed Missed primary
Phase 3 NCT02481791 Jul 2015 → Dec 2019 heart disorder Alder Hey Children's NHS Foundation Trust Unknown No outcome recorded
Phase 3 NCT02033629 May 2014 → May 2019 cardiac valvular defect Imam Abdulrahman Bin Faisal University Completed No outcome recorded
Phase 3 NCT01998165 Nov 2013 → Nov 2014 — Janssen Pharmaceutical K.K. Completed No outcome recorded
Phase 484 trials · 5 met primary · 2 missed
Phase 4 NCT07857356 Oct → Nov 2026 expected — Pamukkale University Recruiting No outcome recorded
Phase 4 NCT07835295 Sep 2026 → Sep 2028 expected — Mayo Clinic Not yet recruiting No outcome recorded
Phase 4 NCT07334132 Apr 2026 → Dec 2029 expected osteoarthritis Region Örebro County Not yet recruiting No outcome recorded
Phase 4 NCT06564857 Nov 2025 → Apr 2027 expected — Nordsjaellands Hospital Recruiting No outcome recorded
Phase 4 NCT07105839 Aug 2025 → Jan 2026 overdue obesity disorder Siirt Training and Research Hospital Not yet recruiting No outcome recorded
Phase 4 NCT01003028 Nov 2024 → Dec 2025 overdue — Seoul National University Hospital Not yet recruiting No outcome recorded
Phase 4 NCT06454292 Jun 2024 → Dec 2025 — Chun Pan Unknown No outcome recorded
Phase 4 NCT06331663 Apr → Jun 2024 — Kaohsiung Medical University Chung-Ho Memorial Hospital Unknown No outcome recorded
Phase 4 NCT05876039 May 2023 → Aug 2024 — Tri-Service General Hospital (TSGH) Completed No outcome recorded
Phase 4 NCT05825560 May 2023 → Jun 2026 — Nîmes University Hospital Completed No outcome recorded
Phase not applicable102 trials · 5 met primary · 4 missed
— NCT07695220 Dec 2026 → Oct 2028 expected intracerebral hemorrhage The Third Affiliated Hospital of Southern Medical University Not yet recruiting No outcome recorded
— NCT06727435 Aug 2026 → Apr 2028 expected — Beijing Tiantan Hospital Not yet recruiting No outcome recorded
— NCT07660861 Jun 2026 → Jun 2027 expected intracranial berry aneurysm, intracranial hypertension Fatih Sultan Mehmet Training and Research Hospital Not yet recruiting No outcome recorded
— NCT07462949 Mar → Apr 2026 — Guangzhou General Hospital of Guangzhou Military Command Completed No outcome recorded
— NCT07640243 Feb → May 2026 overdue cancer, cholangitis Ankara City Hospital Bilkent Recruiting No outcome recorded
— NCT07568405 Jan → Jun 2026 overdue — Université Libre de Bruxelles Enrolling by invitation No outcome recorded
— NCT07328958 Jan → Dec 2026 expected — Sixth Affiliated Hospital, Sun Yat-sen University Recruiting No outcome recorded
— NCT07325669 Jan 2026 → Jan 2027 expected — dilara gocmen Not yet recruiting No outcome recorded
— NCT07310524 Sep → Nov 2025 — Muhammad Rahman Efendi Nasution Completed No outcome recorded
— NCT07092384 Jul → Nov 2025 — Tongji Hospital Completed No outcome recorded
Comparator or background therapy341 trials
Phase 0 NCT06810336 Comparator Mar 2025 → Sep 2027 expected brain injury, brain neoplasm University of Virginia Recruiting No outcome recorded
Phase 0 NCT06205719 Background Jun 2024 → May 2025 — Sichuan Provincial People's Hospital Unknown No outcome recorded
Phase 0 NCT06241131 Background Mar → Dec 2024 — Sichuan Provincial People's Hospital Unknown No outcome recorded
Phase 0 NCT05993039 Comparator Sep 2023 → Dec 2024 auditory system disorder Our Lady of the Lake Hospital Unknown No outcome recorded
Phase 0 NCT04016740 Background Aug 2019 → Feb 2020 coronary artery disorder, delirium Beth Israel Deaconess Medical Center Completed No outcome recorded
Show all 341 trials opens the full record — a long page

Evidence & citations 23 cited values

Every value below carries the sentence it was read from. 569 sources stand behind the page.

FieldValueCited text
Known as Remifentanil “When participants reach the titration endpoint (OAAS score 1 point) during the titration of propofol in the induction, the investigators stop the dosing and switch to a...” NCT04595591 ↗
551

“The aim of this study was to investigate the pharmacodynamic profile of the innovative molecule of remifentanil (group O = Ultiva®) and two unbranded molecules (group A =...” NCT02048293 ↗

“Anesthesia was maintained with sevoflurane (Inhalation Sevoflurane, Brand: Kaiteli, Specification: 120 mL, Approval Number: National Drug Approval H20070172, Manufacturer:...” NCT07192549 ↗

“group BAL included patients who received balanced anesthesia with sevoflurane for 30 min before removal of the flap and throughout the surgery. The TCI group included patients...” PMID 27549313 ↗ Aug 2016

“Maintenance of anesthesia is with target-controlled infusion (Marsh and Minto algorithm) with propofol (Braun Medical, Germany) and remifentanil (GlaxoSmithKline, Great...” NCT01604382 ↗

“In the TIVA group (total intravenous anaesthesia group), induction and maintenance of anaesthesia will be performed using target-controlled infusion (TCI) with propofol...” NCT07325669 ↗

“Propofol and remifentanil will be infused during night-time (8 pm to 6:30 am) for ICU patients with mechanical ventilation or high-flow nasal cannula oxygen therapy (if...” NCT05718024 ↗

“Remifentanil will be administered by IV infusion and maintained at a dose of 0.025 μg/kg/min in non-mechanically ventilated patients and a dose of 0.05 μg/kg/min in...” NCT03207100 ↗

“Recently, remifentanil is commonly used short-acting opioid, and several studies have demonstrated the antitussive effect of remifentanil via effect-site target-controlled...” NCT01291849 ↗

“In the TIVA (Total Intra Venous Anesthesia) group, a combination of propofol (50-150 μg/kg/min) and remifentanil (0.02-0.2 μg/kg/min) was used for general anesthesia instead of...” NCT06558695 ↗

“Anesthesia induction was performed using propofol and remifentanil, followed by maintenance with sevoflurane to ensure adequate anesthetic depth and hemodynamic stability...” NCT07097220 ↗

Show 541 more sources

Known as Fada Remifentanilo “The aim of this study was to investigate the pharmacodynamic profile of the innovative molecule of remifentanil (group O = Ultiva®) and two unbranded molecules (group A =...” NCT02048293 ↗
Known as GI 87084B ChEMBL registry synonym — accepted as the source's own label CHEMBL1005 ↗
Known as GI 87084X ChEMBL registry synonym — accepted as the source's own label CHEMBL1005 ↗
Known as IDS-NR-005 ChEMBL registry synonym — accepted as the source's own label CHEMBL1005 ↗
Known as Ramifentanyl ChEMBL registry synonym — accepted as the source's own label CHEMBL1005 ↗
Known as REM “The aim of this study was to evaluate the efficacy of remifentanil (REM) versus dexmedetomidine (DEX) for treatment of cardiac surgery (CS) patients with moderate to severe NIV...” PMID 33209418 ↗ Oct 2020
Known as remi “Dexmedetomidine/remifentanil (dex/remi group) and midazolam/remifentanil (mida/remi group) were infused 7 days apart.” PMID 17056949 ↗ Nov 2006
Known as Remifentanil ALVOGEN “Remifentanil ALVOGEN®” NCT06640738 ↗
Known as remifentanil HCl “Intra-operative intravenous remifentanil HCl at titratable dose range 0.1-0.25 micrograms/kilogram/minute until start of wound closure” NCT00553553 ↗
Known as Remifentanil Hydrochloride “Morphine hydrochloride, remifentanil hydrochloride” NCT00553553 ↗
6

“Remifentanil Hydrochloride for Injection” NCT07372924 ↗

“Drug: Remifentanil Hydrochloride” NCT04409964 ↗

“Drug: Remifentanil Hydrochloride” NCT05391555 ↗

“Drug: Remifentanil Hydrochloride” NCT02967029 ↗

“Drug: Remifentanil Hydrochloride” NCT04906889 ↗

NCT02999126 ↗

Known as remifentanil hydrochloride (JNJ-268229) “remifentanil hydrochloride (JNJ-268229)” NCT01998165 ↗
Known as remifentanil hydrochloride for injection “remifentanil hydrochloride for injection” NCT04974060 ↗
Known as Remifentanil Laboratorios Chalver de Colombia S.A. “The aim of this study was to investigate the pharmacodynamic profile of the innovative molecule of remifentanil (group O = Ultiva®) and two unbranded molecules (group A =...” NCT02048293 ↗
Known as Remifentanil: Ultiva “remifentanil (ultiva)” NCT02108795 ↗
3

“remifentanil (ultiva)” NCT01915108 ↗

“remifentanil (ultiva)” NCT01919203 ↗

“Remifentanil: Ultiva” NCT00627081 ↗

Known as Remifentanilo ChEMBL registry synonym — accepted as the source's own label CHEMBL1005 ↗
Known as remifentanyl “Compare the opioid based anesthesia with Fentanyl and Remifentanyl to opioid free anesthesia with dexmedetomidine and lidocaine and their effect on postoperative pain.” NCT03417193 ↗
10

NCT01303471 ↗

NCT02602743 ↗

NCT01279499 ↗

NCT01930747 ↗

NCT01998685 ↗

NCT03507634 ↗

NCT00361686 ↗

NCT00419601 ↗

NCT03434691 ↗

NCT00741351 ↗

Known as Ultiva “Remifentanil (Ultiva®; Glaxo-Smith-Kline; Vienna, Austria) will be applied intravenously during 60 minutes through a dedicated infusion pump (TCI Alaris PK Syringe Pump,...” NCT00886106 ↗
14

“Remifentanil (Ultiva; Glaxo-Smith-Kline; Vienna, Austria) will be applied intravenously during 60 minutes through a dedicated infusion pump (TCI Alaris PK Syringe Pump,...” NCT01102101 ↗

“The aim of this study was to investigate the pharmacodynamic profile of the innovative molecule of remifentanil (group O = Ultiva®) and two unbranded molecules (group A =...” NCT02048293 ↗

“Remifentanil (Ultiva, Glaxo SmithKline, Turkey) infusion was started at a dose of 0.05 µg/kg/min-1, 10 minutes before the start of the surgery as baseline infusion and...” NCT04935541 ↗

“Remifentanil (Ultiva), a 4-anilidopiperidine derivative of fentanyl, is an ultra-short-acting micro-opioid receptor agonist indicated to provide analgesia and sedation in...” PMID 16526829 ↗ 2006

“For patients randomized to arm 2, we will inject 30 μg of intravenous Remifentanil (Ultiva®) followed by Xylocaine 1% in a 10 ml bolus (10 mg / ml).” NCT02597699 ↗

“Remifentanil (Ultiva ®; Glaxo-Smith-Kline; Vienna, Austria) at an initial dose of 0.24 µg kg-1 min-1 will be applied iv during 60 minutes.” NCT00789386 ↗

“Four measurements will be obtained at different target plasma concentrations of remifentanil(Ultiva®): 0, 1, 2, and 3 ng/mL.” NCT07568405 ↗

“Drug: Remifentanil (Ultiva). Intraoperative intravenous infusion of remifentanil 0.5-1 μg/kg/min for up to 1 h.” NCT02619032 ↗

“Maintenance will be achieved using remifentanil (Ultiva®) infusion at 0.1-0.3 µg/kg/min and 1 MAC sevoflurane.” NCT07105839 ↗

“High dose remifentanil (Ultiva,Glaxosmithkline, UK)” NCT02455401 ↗

Show 4 more sources

Known as Ultiva (remifentanil) “Ultiva (remifentanil)” NCT01375348 ↗
Action Activate “Remifentanil is a μ-opioid receptor agonist” NCT00567957 ↗
1

“Mu opioid receptor agonist” CHEMBL1005 ↗

Modality Small molecule “Remifentanil is an amidopiperidine derivative with unique pharmacokinetic properties.” NCT00335972 ↗
Route Other “intravenius use” NCT00315536 ↗
Target OPRM1 “Mu opioid receptor agonist” CHEMBL1005 ↗